Solid Biosciences director exercises 3,440 RSUs
Solid Biosciences Inc. director Ian F. Smith increased his equity stake through equity compensation vesting.
Rhea-AI Filing Summary
Solid Biosciences Inc. director Ian F. Smith increased his equity stake through equity compensation vesting. On July 2, 2026, he exercised restricted stock units to acquire 3,440 shares of Common Stock at a price of $0.00 per share, reflecting a conversion of vested awards rather than an open-market purchase.
The filing shows his direct holdings rose to 138,145 shares of Common Stock after the transaction, and he also holds 6,880 Restricted Stock Units. Footnotes state that restricted stock units convert to common stock on a one-for-one basis and were granted on January 2, 2026, vesting in equal quarterly installments over 12 months.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,440 shares exercised/converted
Exercise
2 txns
Insider
SMITH IAN F
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,440 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,440 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 6,880 contracts (Direct);
Common Stock — 138,145 shares (Direct)
Footnotes (2)
- F1. Restricted stock units convert to common stock on a one-for-one basis.
- F2. The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant.
Key Figures
RSUs converted: 3,440 shares
Post-transaction common shares: 138,145 shares
Remaining RSUs: 6,880 units
+2 more
5 metrics
RSUs converted
3,440 shares
Restricted Stock Units converted to Common Stock on July 2, 2026
Post-transaction common shares
138,145 shares
Common Stock directly held by Ian F. Smith after transaction
Remaining RSUs
6,880 units
Restricted Stock Units outstanding after reported conversion
Exercise price
$0.00 per share
Price per share for RSU conversion to Common Stock
Grant date
January 2, 2026
Date RSUs were granted, vesting over 12 months
Key Terms
Restricted Stock Units, derivative security, Form 4, exercise or conversion
4 terms
Restricted Stock Units financial
"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
exercise or conversion financial
"transaction_action: derivative exercise/conversion"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Solid Biosciences (SLDB) director Ian F. Smith report in this Form 4?
Ian F. Smith reported the exercise of restricted stock units into common stock. He acquired 3,440 shares of Solid Biosciences Common Stock through RSU conversion, reflecting vesting of prior equity awards rather than an open-market purchase or sale.
What exactly happened with the 3,440 restricted stock units in Solid Biosciences (SLDB)?
3,440 restricted stock units vested and were converted into an equal number of Solid Biosciences common shares. The conversion price per share was reported as $0.00, consistent with stock-based compensation awards that settle in stock upon vesting rather than through a cash purchase.
Does Ian F. Smith still hold unvested or outstanding restricted stock units in Solid Biosciences?
Yes. Following the reported conversion, Ian F. Smith holds 6,880 restricted stock units. Footnotes indicate these units convert to common stock on a one-for-one basis, reflecting additional equity awards that may settle in shares as they vest under their grant terms.
When were the reported restricted stock units in Solid Biosciences granted and how do they vest?
The restricted stock units were granted on January 2, 2026. According to the filing, they vest in equal quarterly installments beginning three months from the grant date, with the final installment vesting 12 months from that date, creating a one-year vesting schedule.
Is the Form 4 for Solid Biosciences (SLDB) a buy or sell signal for investors?
The Form 4 reflects an RSU exercise, not an open-market trade. It records 3,440 restricted stock units converting into common shares as part of compensation vesting, which is typically viewed as routine and not a direct buy or sell signal on the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
